Moderna building a biomanufacturing facility in Montreal

Via FiercePharma: 

Moderna is expected to announce Friday that it has chosen the Montreal area for a new biomanufacturing production facility that will include a research center.

The Massachusetts-based company, which has seen explosive growth in the wake of its mRNA COVID-19 vaccine, announced last year that it would build a Canadian facility along with other production expansion projects that include plans to build a $500 million plant in Africa.

The exact site of the Canadian mRNA vaccine facility, which is forecast to produce about 30 million doses a year and employ between 200 and 300 people when completed in 2024, hasn’t been determined, but Radio-Canada reported it will be in the greater Montreal region...

Good news for Canadian chemists, as Montreal seems to be a more and more popular destination for biopharma...